US Drug Recall Register
Class III · Low risk Terminated Initiated Oct 19, 2016 (10 years ago)

Invokamet

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Labeling: Incorrect or Missing Package Insert - Xarelto prescribing information outserts may be affixed to the exterior of Invokamet bottles in place of the Invokamet prescribing information outsert.

What was recalled

Invokamet (canagliflozin and metformin HCl) tablets, 150 mg/1,000 mg, 60-count bottle, Rx only, Finished product manufactured by: Janssen Ortho, LLC, Gurabo PR 00778, Manufactured for: Janssen Pharmaceuticals, Inc., Titusville, NJ 08560, NDC 50458-543-60

Recalling firm
Janssen Ortho L.L.C.
NDC code
50458-543-60
Origin
PR, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0115-2017

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Metformin recalls

See all
Class II · Moderate risk Ongoing

Synjardy XR Tablets

Reason CGMP Deviations: An incorrect detergent was used and the required swab sampling was not performed on a production hopper that had previously been used for a different product.

Boehringer Ingelheim Pharmaceuticals, Inc. D-0657-2026
Class II · Moderate risk Terminated

Metformin Hydrochloride Extended-Release Tablets

Reason Presence of Foreign Tablets/Capsules: A Paracetamol 500 mg tablet was found in a 1000-count bottle of Metformin HCL ER Tablets USP, 500 mg.

Granules Pharmaceuticals Inc. NDC 82009-117-10 D-0192-2025
Class II · Moderate risk Terminated

Metformin hydrochloride Extended-Release Tablets

Reason CGMP Deviations: Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.

Teva Pharmaceuticals USA Inc NDC 00591-2720-60 D-0441-2023